378 related articles for article (PubMed ID: 16009814)
21. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318
[TBL] [Abstract][Full Text] [Related]
22. Spectrum of Physiologic and Pathologic Skeletal Muscle (18)F-FDG Uptake on PET/CT.
Karunanithi S; Soundararajan R; Sharma P; Naswa N; Bal C; Kumar R
AJR Am J Roentgenol; 2015 Aug; 205(2):W141-9. PubMed ID: 26001118
[TBL] [Abstract][Full Text] [Related]
23. False-positive FDG PET uptake--the role of PET/CT.
Rosenbaum SJ; Lind T; Antoch G; Bockisch A
Eur Radiol; 2006 May; 16(5):1054-65. PubMed ID: 16365730
[TBL] [Abstract][Full Text] [Related]
24. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer.
Pauleit D; Zimmermann A; Stoffels G; Bauer D; Risse J; Flüss MO; Hamacher K; Coenen HH; Langen KJ
J Nucl Med; 2006 Feb; 47(2):256-61. PubMed ID: 16455631
[TBL] [Abstract][Full Text] [Related]
25. False-positive uptake on 2-[¹⁸F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging.
Culverwell AD; Scarsbrook AF; Chowdhury FU
Clin Radiol; 2011 Apr; 66(4):366-82. PubMed ID: 21356398
[TBL] [Abstract][Full Text] [Related]
26. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603
[TBL] [Abstract][Full Text] [Related]
27. Prospective evaluation of physiologic uptake detected with true whole-body 18F-FDG PET/CT in healthy subjects.
Reinking MF; Osman MM
J Nucl Med Technol; 2009 Mar; 37(1):31-7. PubMed ID: 19223428
[TBL] [Abstract][Full Text] [Related]
28. Combined 18F-FDG-PET/CT imaging of the head and neck. An approach to metal artifact correction.
Schäfers KP; Raupach R; Beyer T
Nuklearmedizin; 2006; 45(5):219-22. PubMed ID: 17043733
[TBL] [Abstract][Full Text] [Related]
29. [Current status of nuclear medicine clinical application of FDG-PET for cancer diagnosis. Head and neck cancer].
Nakasone Y; Mogi K; Endo K
Nihon Igaku Hoshasen Gakkai Zasshi; 2002 May; 62(6):258-64. PubMed ID: 12073631
[TBL] [Abstract][Full Text] [Related]
30. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient.
Lonneux M; Lawson G; Ide C; Bausart R; Remacle M; Pauwels S
Laryngoscope; 2000 Sep; 110(9):1493-7. PubMed ID: 10983949
[TBL] [Abstract][Full Text] [Related]
31. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
32. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
Menda Y; Graham MM
Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
[TBL] [Abstract][Full Text] [Related]
33. In vivo spatial correlation between (18)F-BPA and (18)F-FDG uptakes in head and neck cancer.
Kobayashi K; Kurihara H; Watanabe Y; Murakami N; Inaba K; Nakamura S; Wakita A; Okamoto H; Umezawa R; Takahashi K; Igaki H; Ito Y; Yoshimoto S; Shigematsu N; Itami J
Appl Radiat Isot; 2016 Sep; 115():138-146. PubMed ID: 27372808
[TBL] [Abstract][Full Text] [Related]
34. Clinical value of combined positron emission tomography/computed tomography imaging in the interpretation of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography studies in cancer patients.
Yeung HW; Schöder H; Smith A; Gonen M; Larson SM
Mol Imaging Biol; 2005; 7(3):229-35. PubMed ID: 15912427
[TBL] [Abstract][Full Text] [Related]
35. Atlas of confounding factors in head and neck PET/CT imaging.
Bhargava P; Rahman S; Wendt J
Clin Nucl Med; 2011 May; 36(5):e20-9. PubMed ID: 21467845
[TBL] [Abstract][Full Text] [Related]
36. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
[TBL] [Abstract][Full Text] [Related]
37. Normal Patterns and Pitfalls of FDG Uptake in the Head and Neck.
Gray BR; Koontz NA
Semin Ultrasound CT MR; 2019 Oct; 40(5):367-375. PubMed ID: 31635764
[TBL] [Abstract][Full Text] [Related]
38. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers.
Andrade RS; Heron DE; Degirmenci B; Filho PA; Branstetter BF; Seethala RR; Ferris RL; Avril N
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1315-22. PubMed ID: 16750327
[TBL] [Abstract][Full Text] [Related]
39. Persistent non-specific FDG uptake on PET imaging following hip arthroplasty.
Zhuang H; Chacko TK; Hickeson M; Stevenson K; Feng Q; Ponzo F; Garino JP; Alavi A
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1328-33. PubMed ID: 12271415
[TBL] [Abstract][Full Text] [Related]
40. Focal F-18 fluoro-deoxy-glucose accumulation in the lung parenchyma in the absence of CT abnormality in PET/CT.
Karantanis D; Subramaniam RM; Mullan BP; Peller PJ; Wiseman GA
J Comput Assist Tomogr; 2007; 31(5):800-5. PubMed ID: 17895795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
